Characterization of GBV-C infection in HIV-1 infected patients.
Filippo Canducci(Vita-Salute San Raffaele University), Massimo Clementi(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Eduardo Boeri(CS Diagnostics), Giulia Gallotta(Vita-Salute San Raffaele University), Giliola Calori(University of Milan), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), S. Racca(CS Diagnostics), Maria Angela Grasso
PubMed
June 9, 2004
Cited by 4
Related Papers
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
|Hepatology|1997|178
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173